8-KThe WireRoutine
Shareholder Vote
Filed Jun 7, 2024 · 2y ago · Accession 0001558370-24-009009
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Aclaris Therapeutics, Inc.
- Ticker
- ACRS
- CIK
- 1557746
- Form type
- 8-K
- Filing date
- Jun 7, 2024
- Report date
- Jun 6, 2024
- Document
- acrs-20240606x8k.htm
- Size
- 170 KB